191 related articles for article (PubMed ID: 23581420)
1. Toll-like receptor 2 gene polymorphisms and cancer susceptibility: a meta-analysis.
Wang X; Li J; Xie W; Zhang W; Chang Y
Neoplasma; 2013; 60(4):459-67. PubMed ID: 23581420
[TBL] [Abstract][Full Text] [Related]
2. [The correlation between polymorphisms of Toll-like receptor 2 and Toll-like receptor 9 and susceptibility to gastric cancer].
Zeng HM; Pan KF; Zhang Y; Zhang L; Ma JL; Zhou T; Su HJ; Li WQ; Li JY; You WC
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Jul; 45(7):588-92. PubMed ID: 22041559
[TBL] [Abstract][Full Text] [Related]
3. CASP8 -652 6N del polymorphism and cancer risk: a meta-analysis of 30 case-control studies in 50,112 subjects.
Zhang F; Yang Y; Guo C; Wang Y
Mutagenesis; 2012 Sep; 27(5):559-66. PubMed ID: 22513478
[TBL] [Abstract][Full Text] [Related]
4. Intron 3 16 bp duplication polymorphism of TP53 contributes to cancer susceptibility: a meta-analysis.
Hu Z; Li X; Qu X; He Y; Ring BZ; Song E; Su L
Carcinogenesis; 2010 Apr; 31(4):643-7. PubMed ID: 20089604
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of CD14 and Toll-like receptor-2 (TLR2) in patients with ulcerative colitis.
Wang F; Tahara T; Arisawa T; Shibata T; Nakamura M; Fujita H; Iwata M; Kamiya Y; Nagasaka M; Takahama K; Watanabe M; Hirata I; Nakano H
J Gastroenterol Hepatol; 2007 Jun; 22(6):925-9. PubMed ID: 17565650
[TBL] [Abstract][Full Text] [Related]
6. TLR-2 gene polymorphisms and susceptibility to cancer: evidence from meta-analysis.
Wang XQ; Liu L; Liu Y; Zhang K
Genet Test Mol Biomarkers; 2013 Dec; 17(12):864-72. PubMed ID: 23992203
[TBL] [Abstract][Full Text] [Related]
7. Human Toll-like receptor 2 genetic polymorphisms with tuberculosis susceptibility: A systematic review and meta-analysis.
Chen R; Wang X; Li Z; Dai Y; Du W; Wu L
Cytokine; 2023 Dec; 172():156405. PubMed ID: 37883839
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants of toll-like receptor 2 and 5, helicobacter pylori infection, and risk of gastric cancer and its precursors in a chinese population.
Zeng HM; Pan KF; Zhang Y; Zhang L; Ma JL; Zhou T; Su HJ; Li WQ; Li JY; Gerhard M; Classen M; You WC
Cancer Epidemiol Biomarkers Prev; 2011 Dec; 20(12):2594-602. PubMed ID: 21994405
[TBL] [Abstract][Full Text] [Related]
9. The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C.
Nischalke HD; Coenen M; Berger C; Aldenhoff K; Müller T; Berg T; Krämer B; Körner C; Odenthal M; Schulze F; Grünhage F; Nattermann J; Sauerbruch T; Spengler U
Int J Cancer; 2012 Mar; 130(6):1470-5. PubMed ID: 21500195
[TBL] [Abstract][Full Text] [Related]
10. Four polymorphisms of the CAPN 10 gene and their relationship to polycystic ovary syndrome susceptibility: a meta-analysis.
Huang M; Xiao J; Zhao X; Liu C; Chen Q
Clin Endocrinol (Oxf); 2012 Mar; 76(3):431-8. PubMed ID: 21906115
[TBL] [Abstract][Full Text] [Related]
11. Significant association between toll-like receptor gene polymorphisms and gallbladder cancer.
Srivastava K; Srivastava A; Kumar A; Mittal B
Liver Int; 2010 Aug; 30(7):1067-72. PubMed ID: 20492496
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in cancer: a meta-analysis.
Jing JJ; Li M; Yuan Y
Gene; 2012 May; 499(2):237-42. PubMed ID: 22441122
[TBL] [Abstract][Full Text] [Related]
13. Three common TP53 polymorphisms in susceptibility to breast cancer, evidence from meta-analysis.
Hu Z; Li X; Yuan R; Ring BZ; Su L
Breast Cancer Res Treat; 2010 Apr; 120(3):705-14. PubMed ID: 19657731
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptors gene polymorphisms may confer increased susceptibility to breast cancer development.
Theodoropoulos GE; Saridakis V; Karantanos T; Michalopoulos NV; Zagouri F; Kontogianni P; Lymperi M; Gazouli M; Zografos GC
Breast; 2012 Aug; 21(4):534-8. PubMed ID: 22560646
[TBL] [Abstract][Full Text] [Related]
15. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
[TBL] [Abstract][Full Text] [Related]
16. Lack of association of three common polymorphisms in toll-like receptors (TLRs), TLR2+597T>C, +1350C>T and Arg753Gln with cancer risk: a meta-analysis.
Yang X; Wang XX; Qiu MT; Hu JW; Yin R; Xu L; Zhang Q
Asian Pac J Cancer Prev; 2013; 14(10):5871-6. PubMed ID: 24289592
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism in HLA-G 3'UTR 14-bp ins/del and risk of cancer: a meta-analysis of case-control study.
Li T; Huang H; Liao D; Ling H; Su B; Cai M
Mol Genet Genomics; 2015 Aug; 290(4):1235-45. PubMed ID: 25573780
[TBL] [Abstract][Full Text] [Related]
18. Involvement of Toll-like receptors in cervical cancer susceptibility among Tunisian women.
Zidi S; Verdi H; Yilmaz-Yalcin Y; Yazici AC; Gazouani E; Mezlini A; Atac FB; Yacoubi-Loueslati B
Bull Cancer; 2014 Oct; 101(10):E31-5. PubMed ID: 25373689
[TBL] [Abstract][Full Text] [Related]
19. TLR2 Arg677Trp but not TLR2 -196 to -174 ins/del and Arg753Gln polymorphism alter the risk of peptic ulcer in north of Iran.
Habibzadeh M; Tourani M; Shokri-Shirvani J; Mostafazadeh A; Khafri S; Nouri HR
J Chin Med Assoc; 2018 Jan; 81(1):25-30. PubMed ID: 28844484
[TBL] [Abstract][Full Text] [Related]
20. Association between TLR2 and TLR4 Gene Polymorphisms and the Susceptibility to Inflammatory Bowel Disease: A Meta-Analysis.
Cheng Y; Zhu Y; Huang X; Zhang W; Han Z; Liu S
PLoS One; 2015; 10(5):e0126803. PubMed ID: 26023918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
